
HomeSpecialty IngredientAlfabin™ by Cepham
Alfabin™ by Cepham
Alfabin™ by Cepham
Alfabin™ by Cepham is a highly purified extract of Rauwolfia vomitoria root, standardized to 98% rauwolscine (α-yohimbine). This natural alkaloid functions as a selective α2-adrenergic receptor antagonist with additional serotonin receptor activity, supporting advanced formulation needs in metabolic and performance categories. Produced through a proprietary extraction process ensuring extra-pure grade and impurity-free composition, Alfabin™ provides enhanced bioavailability, low dosage efficiency, and stability, making it ideal for specialized dietary supplement and functional product applications.
0.0
0.0 out of 5 stars (based on 0 endorsements)
General
Item #:
Company:
Technology:
Proprietary extraction process, NMR-affirmed purity
Name:
Alfabin™
Ingredient/s:
Rauwolscine (α-Yohimbine)
Categories:
Energy Booster, Health & Wellness, Metabolic Health, Sports Performance, Weight Management
Dosage (min):
Dosage (max):
Price kg:
MOQ:
Botanical Names:
Rauwolfia vomitoria
Active/s:
Rauwolscine (α-Yohimbine)
Assay:
Standardized to 98% Rauwolscine (α-Yohimbine)
Country of Origin:
Suppliers:
Cepham Inc.
Contact Information
Email:
Documents (Coming Soon)
Upgrade your account to access documents
COMING SOON
Cheat Sheet Card
100% Natural
Vegan
Gluten Free
Non-GMO
GRAS
Water Soluble
Wild-Harvested
Allergen Free
Key Certifications
Halal Certified
Kosher Certified
Vegan Certified
USDA Organic
NON-GMO Project Verified
Gluten-Free Certified
Send an Inquiry
Ingredient Highlights
Alfabin™ is clinically researched and shown to help:
- Supports healthy blood sugar levels.*
- Promotes healthy glucose metabolism.*
- Supports healthy insulin sensitivity.*
- Maintains healthy carbohydrate metabolism.*
- Supports healthy weight management efforts.*
- Offers antioxidant protection.*
Featured Content
Product type
General Health
Endorsement
0.0
0.0 out of 5 stars (based on 0 endorsements)
Excellent0%
Very good0%
Average0%
Poor0%
Terrible0%
There are no reviews yet. Be the first one to write one.












